Active Ingredient History
Vedolizumab, sold under the brand name Entyvio, is a monoclonal antibody medication developed by Millennium Pharmaceuticals, Inc. for the treatment of ulcerative colitis and Crohn's disease. It binds to integrin α4β7, blocking the α4β7 integrin results in gut-selective anti-inflammatory activity. Wikipedia
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Biological Products (Phase 4)
Carcinoma, Non-Small-Cell Lung (Phase 1/Phase 2)
Celiac Disease (Phase 2)
Cholangitis, Sclerosing (Phase 3)
Colitis (Phase 1/Phase 2)
Diabetes Mellitus, Type 1 (Early Phase 1)
Diet Therapy (Early Phase 1)
Graft vs Host Disease (Phase 2)
Healthy Volunteers (Phase 1)
Hematopoietic Stem Cells (Phase 3)
Hematopoietic Stem Cell Transplantation (Phase 2)
HIV (Phase 1)
HIV Infections (Phase 2)
Immune System Diseases (Phase 2)
Inflammatory Bowel Diseases (Phase 4)
Leukemia (Phase 3)
Leukemia, Biphenotypic, Acute (Phase 3)
Leukemia, Myelomonocytic, Juvenile (Phase 3)
Lung Neoplasms (Early Phase 1)
Lymphoma (Phase 3)
Macular Degeneration (Phase 1)
Melanoma (Phase 1/Phase 2)
Mesalamine (Phase 4)
Myelodysplastic Syndromes (Phase 3)
Neoplasm Metastasis (Phase 1/Phase 2)
Neoplasms (Phase 1/Phase 2)
Pouchitis (Phase 4)
Psoriasis (Phase 4)
Self Efficacy (Phase 4)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
